Some 28 million Americans suffer from asthma attacks. Now, researchers have developed a new method that they say could ...

Researchers at Mass General Brigham and Karolinska Institutet have identified a new method to predict asthma exacerbations ...

In this heavy-hitting chest session, Kali Muscle joins forces with Big Boy and the Strength Cartel crew to move serious ...

Associations between asthma and dementia differed based on the patient’s age and asthma control, according to a study ...

Running in cold weather can irritate the lungs, causing coughing, chest tightness, and breathlessness due to cold, dry air.

The American College of Chest Physicians (CHEST) recently released a new clinical guideline on biologic management in severe ...

Exdensur (depemokimab) approved by US FDA for the treatment of severe asthma · Exdensur is the first and only ultra-long-acting biologic with twice-yearly dosing approved for patients with severe ...

Exdensur is the first and only ultra-long-acting biologic with twice-yearly dosing approved for patients with severe asthma with an eosinophilic phenotype Approval based on SWIFT trials showing ...

Depemokimab-ulaa (Exdensur) is approved for severe asthma with an eosinophilic phenotype, offering protection with just two doses annually. Phase 3 trials demonstrated significant reductions in asthma ...

LONDON, Dec 16 (Reuters) - The U.S. health regulator has approved GSK's (GSK.L), opens new tab add-on treatment for severe asthma, offering a less frequently dosed option, but rejected its use for ...

Credit: Getty Images The recently-released CHEST guideline on Biologic Management in Severe Asthma for Adults offers recommendations on choosing and switching among biologic therapies. The American ...